Bank of New York Mellon’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.67M | Sell |
401,283
-1,801
| -0.4% | -$25.7K | ﹤0.01% | 2477 |
|
|
2026
Q1 | $6.77M | Sell |
403,084
-8,559
| -2% | -$153K | ﹤0.01% | 2147 |
|
|
2025
Q4 | $6.6M | Buy |
411,643
+18,214
| +5% | +$271K | ﹤0.01% | 2167 |
|
|
2025
Q3 | $4.86M | Sell |
393,429
-12,079
| -3% | -$142K | ﹤0.01% | 2334 |
|
|
2025
Q2 | $4.67M | Sell |
405,508
-4,938
| -1% | -$58.6K | ﹤0.01% | 2301 |
|
|
2025
Q1 | $6.15M | Sell |
410,446
-39,567
| -9% | -$662K | ﹤0.01% | 2115 |
|
|
2024
Q4 | $7.79M | Sell |
450,013
-28,026
| -6% | -$541K | ﹤0.01% | 2053 |
|
|
2024
Q3 | $8.86M | Sell |
478,039
-38,080
| -7% | -$765K | ﹤0.01% | 1993 |
|
|
2024
Q2 | $10.5M | Buy |
516,119
+38,726
| +8% | +$685K | ﹤0.01% | 1939 |
|
|
2024
Q1 | $8.15M | Buy |
477,393
+13,355
| +3% | +$210K | ﹤0.01% | 2066 |
|
|
2023
Q4 | $8.19M | Buy |
464,038
+97,784
| +27% | +$1.97M | ﹤0.01% | 2089 |
|
|
2023
Q3 | $8.79M | Sell |
366,254
-35,273
| -9% | -$866K | ﹤0.01% | 2015 |
|
|
2023
Q2 | $9.34M | Buy |
401,527
+119,882
| +43% | +$2.71M | ﹤0.01% | 1982 |
|
|
2023
Q1 | $6.21M | Sell |
281,645
-1,179
| -0.4% | -$27.6K | ﹤0.01% | 2182 |
|
|
2022
Q4 | $5.73M | Sell |
282,824
-5,358
| -2% | -$104K | ﹤0.01% | 2268 |
|
|
2022
Q3 | $3.88M | Sell |
288,182
-9,010
| -3% | -$152K | ﹤0.01% | 2433 |
|
|
2022
Q2 | $5.89M | Sell |
297,192
-5,770
| -2% | -$153K | ﹤0.01% | 2227 |
|
|
2022
Q1 | $9.58M | Sell |
302,962
-1,467
| -0.5% | -$41.1K | ﹤0.01% | 2087 |
|
|
2021
Q4 | $6.79M | Sell |
304,429
-10,599
| -3% | -$276K | ﹤0.01% | 2305 |
|
|
2021
Q3 | $8.74M | Sell |
315,028
-8,871
| -3% | -$270K | ﹤0.01% | 2199 |
|
|
2021
Q2 | $12.6M | Sell |
323,899
-60,072
| -16% | -$2.15M | ﹤0.01% | 2004 |
|
|
2021
Q1 | $11.1M | Sell |
383,971
-1,743
| -0.5% | -$59.5K | ﹤0.01% | 2033 |
|
|
2020
Q4 | $10.2M | Sell |
385,714
-10,882
| -3% | -$222K | ﹤0.01% | 1995 |
|
|
2020
Q3 | $6.05M | Buy |
396,596
+27,868
| +8% | +$584K | ﹤0.01% | 2122 |
|
|
2020
Q2 | $7.49M | Sell |
368,728
-992,082
| -73% | -$17.8M | ﹤0.01% | 1993 |
|
|
2020
Q1 | $14.1M | Buy |
1,360,810
+588,848
| +76% | +$16.5M | ﹤0.01% | 1505 |
|
|
2019
Q4 | $29.1M | Buy |
771,962
+35,649
| +5% | +$1.6M | 0.01% | 1341 |
|
|
2019
Q3 | $34.3M | Buy |
736,313
+158,970
| +28% | +$7.39M | 0.01% | 1183 |
|
|
2019
Q2 | $30.2M | Buy |
577,343
+62,894
| +12% | +$3.69M | 0.01% | 1281 |
|
|
2019
Q1 | $35.5M | Buy |
514,449
+25,331
| +5% | +$1.7M | 0.01% | 1197 |
|
|
2018
Q4 | $29.2M | Sell |
489,118
-34,231
| -7% | -$2.95M | 0.01% | 1233 |
|
|
2018
Q3 | $60.6M | Sell |
523,349
-7,951
| -1% | -$897K | 0.02% | 890 |
|
|
2018
Q2 | $67.1M | Sell |
531,300
-8,288
| -2% | -$1.01M | 0.02% | 812 |
|
|
2018
Q1 | $58.4M | Buy |
539,588
+1,365
| +0.3% | +$151K | 0.02% | 904 |
|
|
2017
Q4 | $59M | Sell |
538,223
-29,083
| -5% | -$2.9M | 0.02% | 911 |
|
|
2017
Q3 | $56M | Buy |
567,306
+332,620
| +142% | +$32.2M | 0.02% | 910 |
|
|
2017
Q2 | $23.8M | Sell |
234,686
-3,916
| -2% | -$422K | 0.01% | 1448 |
|
|
2017
Q1 | $27.6M | Buy |
238,602
+9,420
| +4% | +$1.09M | 0.01% | 1355 |
|
|
2016
Q4 | $27.5M | Sell |
229,182
-596
| -0.3% | -$66K | 0.01% | 1332 |
|
|
2016
Q3 | $25.8M | Sell |
229,778
-2,458
| -1% | -$283K | 0.01% | 1292 |
|
|
2016
Q2 | $28.8M | Buy |
232,236
+6,063
| +3% | +$732K | 0.01% | 1173 |
|
|
2016
Q1 | $25.4M | Buy |
226,173
+12,874
| +6% | +$1.34M | 0.01% | 1259 |
|
|
2015
Q4 | $23.2M | Buy |
213,299
+39,296
| +23% | +$4.5M | 0.01% | 1309 |
|
|
2015
Q3 | $17.4M | Buy |
174,003
+39,520
| +29% | +$4.3M | 0.01% | 1506 |
|
|
2015
Q2 | $15.3M | Sell |
134,483
-171
| -0.1% | -$20.7K | ﹤0.01% | 1674 |
|
|
2015
Q1 | $14.1M | Buy |
134,654
+15,929
| +13% | +$1.7M | ﹤0.01% | 1740 |
|
|
2014
Q4 | $14.3M | Sell |
118,725
-11,836
| -9% | -$1.55M | ﹤0.01% | 1692 |
|
|
2014
Q3 | $19.1M | Sell |
130,561
-4,457
| -3% | -$688K | 0.01% | 1458 |
|
|
2014
Q2 | $22.6M | Buy |
135,018
+325
| +0.2% | +$57.8K | 0.01% | 1394 |
|
|
2014
Q1 | $26.7M | Sell |
134,693
-495
| -0.4% | -$93.4K | 0.01% | 1283 |
|
|
2013
Q4 | $25.8M | Sell |
135,188
-1,364
| -1% | -$254K | 0.01% | 1301 |
|
|
2013
Q3 | $23.1M | Sell |
136,552
-1,514
| -1% | -$235K | 0.01% | 1317 |
|
|
2013
Q2 | $20.9M | Buy |
+138,066
| New | +$19.6M | 0.01% | 1351 |
|
Other funds holding CLB
CAMG
ECM
RHJA
Bank of New York Mellon's CLB Position: Q2 2026 in Review
Bank of New York Mellon reduced its Core Laboratories (CLB) stake by 0.45% in Q2 2026, selling an estimated $25.7K and leaving 401,283 shares worth $4.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2477.
Bank of New York Mellon first reported a position in CLB in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.1M in Q2 2018. 78 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Bank of New York Mellon held 401,283 shares of Core Laboratories worth $4.67M as of Q2 2026.
- Bank of New York Mellon sold 1,801 Core Laboratories shares in Q2 2026, an estimated $25.7K.
- Core Laboratories made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2477 holding.
- Bank of New York Mellon first reported a position in Core Laboratories in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Core Laboratories position peaked at $67.1M in Q2 2018.
- 78 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.